|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
PR Newswire
May 8
Comment
UNION CITY, Calif., May 8, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at
PR Newswire
Apr 26
Comment
UNION CITY, Calif., April 26, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the fourth quarter and fiscal year ended March 31,
Benzinga
Apr 23
Comment
In a report released earlier today, Feltl and Company reiterated its Buy rating for Abaxis, Inc. (NASDAQ: ABAX), along with slightly raising its price target from $34.25 to $35.75.
Feltl and Company said in the report “We believe that Abaxis...
PR Newswire
Apr 16
Comment
UNION CITY, Calif., April 16, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the fourth quarter
PR Newswire
Mar 13
Comment
UNION CITY, Calif., March 13, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present
PR Newswire
Feb 29
Comment
UNION CITY, Calif., Feb. 29, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer , will present
Benzinga
Jan 6
Comment
Feltl and Company has initiated coverage on Abaxis (NASDAQ: ABAX) with a Buy rating and $34.25 price target.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of...
StreetInsider.com
Dec 27
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Abaxis+%28ABAX%29+Veterinary+Division+Announces+Development+of+Quantitative+Lyme+Test/7042683.html for the full story.
Stock Blog Hub
Dec 1
Comment
Following the company’s solid second quarter 2011 results, which were ahead of the Zacks Consensus Estimates, we have upgraded our recommendation on Abaxis (ABAX) to Neutral with a target price of $26.00.
The company reported EPS of 15 cents...
Stock Blog Hub
Dec 1
Comment
Alere (ALR), a medical products company focused on integrating rapid diagnostics with health management, recently revealed that it has taken over Arriva Medical, a prominent vendor of diabetes testing supplies for patients residing at...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
